PALB2 and breast cancer: This study, the largest experiment to date to systematically sequence the coding and exon-flanking regions of these genes in a population-based series of BC cases and controls, provides additional confirmation that protein-truncating mutations in ATM, CHEK2 and PALB2 are associated with increased BC risks.